Muutke küpsiste eelistusi

E-raamat: Management of Dementia from the Preclinical Stage: An Update

Edited by
  • Formaat: PDF+DRM
  • Sari: Medicine
  • Ilmumisaeg: 13-Jan-2026
  • Kirjastus: Springer Verlag, Singapore
  • Keel: eng
  • ISBN-13: 9789819552221
  • Formaat - PDF+DRM
  • Hind: 147,58 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
  • Formaat: PDF+DRM
  • Sari: Medicine
  • Ilmumisaeg: 13-Jan-2026
  • Kirjastus: Springer Verlag, Singapore
  • Keel: eng
  • ISBN-13: 9789819552221

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

This book introduces dementia and its related disorder featured with the updated information from basic sciences such as newly found biomarkers to clinical treatments. The treatments contain the pharmacological including updated clinical trials and non-pharmacological interventions from traditional multiple modalities intervention to digital medicines including basic concept of artificial intelligence (AI) with its clinical application.





It updates the clinical phenotypes of successful aging to dementia along with accompanied biomarkers in various stages to help readers how to recognize these stages scientifically. Meanwhile, authors updates the risks factors with their managements such as cardiovascular risks, atrial fibrillation, diabetic mellitus, hypertension, or metabolic syndrome etc., or other manipulable risks.





AI application is increasing recently. Authors introduce basic concepting of how AI working and computing to assist professional physicians or researchers in clinical managements or basic researches.





Authors provide and update the innovative managements of non-invasive interventions for dementia such as gamma oscillation or other physical intervention with their clinical applications.





The new concepts of epileptic discharge, brain electrical activity to dementia, are also reported and summarized in the book to have a new vision of degenerative process of cerebral aging.
The dementia cascade: from the preclinical stage.- Using EEG in dementia
from diagnostic to clinical outcomes.- The neuroimaging in the dementia: CT,
MRI, SPECT, and molecular neuroimaging.- Neuropsychiatric manifestation along
with aging, MCI, and dementia.- Vascular contribution and risks to cognitive
disorder.- Neuropathological diagnoses of dementia.- Interrupt the
homeostasis of proteomics to dementia.- Applying new devices and IoT in
dementia management.- Pharmacological prevision medicine to treatment
dementia.- The digital medicines for the management of dementia with its
related disorder.- Significances of fluid biomarkers to dementia.- The change
of dementia presentation during past decades.
Editor Yuan-Han Yang is the Director of and a professor in Neuroscience Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.